AINewsnow

How Do Pharma Companies Analyze Net Price and Gross-to-Net

This story is from 2026-09-28. It is preserved in the archive; the latest stories are on the live feed.

For pharmaceutical companies, the price shown on a list or reference sheet is rarely the amount the manufacturer ultimately retains. Discounts, rebates, chargebacks, patient assistance, payer agreements, fees, and other concessions can all reduce the revenue generated from a product. That is where…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-09-28 17:03 · DEV Community — AI
    How Do Pharma Companies Analyze Net Price and Gross-to-Net

More stories

  1. NVIDIA Open Agent Safety Platform: A Reference for Continuous In-Silicon Agent Monitoring — NVIDIA Technical Blog
  2. Launching Meta Enterprise Platform — Meta Newsroom
  3. Heads of OpenAI and Anthropic called to face Senate inquiry after rogue agent incidents — The Guardian AI
  4. Scoop: Anthropic's Dario Amodei to have White House dinner with Trump — Axios AI+
  5. Meta Taps MongoDB CEO to Lead New Enterprise AI Platform — Bloomberg AI
  6. Bill Gates says unchecked AI could ‘cause a billion deaths’ in call for regulation — The Guardian AI
  7. Unsecured OpenAI agents posted 53 user images on the internet without the lab's knowledge — TechCrunch AI
  8. AI agent startup Instinct raised a $1B Series C from Sequoia, Benchmark, and Coatue at a $10B valuation and details recent products, such as a concierge service (Utkarsh Shetti/Reuters) — Techmeme

Get the daily brief of stories like this at 6:30 every morning →